肌钙蛋白水平与年龄和死亡率的相关性:英国五个急性护理中心25万患者队列研究
该回顾性队列研究纳入英国五个心血管中心2010至2017年间连续接受肌钙蛋白检测的257948例患者,分析峰值肌钙蛋白水平与全因死亡率的关系。中位随访1198天期间死亡55850例(21.7%)。肌钙蛋白阳性(高于正常上限)与3年死亡率风险升高相关(HR 3.2,95%CI 3.1-3.2),各年龄组绝对3年死亡率增加约15个百分点,超额死亡集中在最初几周。非ACS患者肌钙蛋白与死亡率呈直接正相关,而ACS患者呈倒U形关系。
要点
- 肌钙蛋白阳性(高于正常上限)与3年死亡率风险升高相关(HR 3.2,95%CI 3.1-3.2)。
- 各年龄组肌钙蛋白阳性者绝对3年死亡率增加约15个百分点。
- 肌钙蛋白阳性相关超额死亡主要集中在最初几周。
- 非ACS患者(n=120049)肌钙蛋白水平与死亡率呈直接正相关。
- ACS患者(n=14468)峰值肌钙蛋白>70×ULN时死亡率呈 paradoxical 下降(倒U形关系)。
适用人群与场景
- 2010至2017年间在英国五个心血管中心因任何临床原因接受肌钙蛋白检测的连续患者257948例。
- 非ACS患者n=120049,ACS患者n=14468。
诊断标准与关键阈值
- 肌钙蛋白阳性定义为高于正常上限(即高于各实验室第99百分位上限)。
- 峰值肌钙蛋白为患者住院期间测得的最高肌钙蛋白水平,标准化为各实验室第99百分位上限的倍数。
研究设计与关键结果
- 回顾性队列研究,纳入257948例连续患者,中位随访1198天(四分位距514-1866天),死亡55850例(21.7%)。
- 肌钙蛋白阳性与3年死亡率风险升高相关(HR 3.2,95%CI 3.1-3.2)。
- 18-29岁组HR 10.6(95%CI 8.5-13.3),>90岁组HR 1.5(95%CI 1.4-1.6)。
- 各年龄组肌钙蛋白阳性者绝对3年死亡率增加约15个百分点。
- 非ACS患者肌钙蛋白水平与死亡率呈直接正相关;ACS患者呈倒U形关系,峰值肌钙蛋白>70×ULN时死亡率 paradoxical 下降。
- ACS患者中,倒U形关系在侵入性管理组多变量调整后持续存在,而非侵入性管理组呈直接正相关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 肌钙蛋白阳性(即使仅轻度高于正常)与临床重要的死亡率增加相关,且与年龄无关,超额死亡集中在最初几周。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the relation between age and troponin level and its prognostic implication.
DESIGN: Retrospective cohort study.
SETTING: Five cardiovascular centres in the UK National Institute for Health Research Health Informatics Collaborative (UK-NIHR HIC).
PARTICIPANTS: 257 948 consecutive patients undergoing troponin testing for any clinical reason between 2010 and 2017.
MAIN OUTCOME MEASURE: All cause mortality.
RESULTS: 257 948 patients had troponin measured during the study period. Analyses on troponin were performed using the peak troponin level, which was the highest troponin level measured during the patient's hospital stay. Troponin levels were standardised as a multiple of each laboratory's 99th centile of the upper limit of normal (ULN). During a median follow-up of 1198 days (interquartile range 514-1866 days), 55 850 (21.7%) deaths occurred. A positive troponin result (that is, higher than the upper limit of normal) signified a 3.2 higher mortality hazard (95% confidence interval 3.1 to 3.2) over three years. Mortality varied noticeably with age, with a hazard ratio of 10.6 (8.5 to 13.3) in 18-29 year olds and 1.5 (1.4 to 1.6) in those older than 90. A positive troponin result was associated with an approximately 15 percentage points higher absolute three year mortality across all age groups. The excess mortality with a positive troponin result was heavily concentrated in the first few weeks. Results were analysed using multivariable adjusted restricted cubic spline Cox regression. A direct relation was seen between troponin level and mortality in patients without acute coronary syndrome (ACS, n=120 049), whereas an inverted U shaped relation was found in patients with ACS (n=14 468), with a paradoxical decline in mortality at peak troponin levels >70×ULN. In the group with ACS, the inverted U shaped relation persisted after multivariable adjustment in those who were managed invasively; however, a direct positive relation was found between troponin level and mortality in patients managed non-invasively.
CONCLUSIONS: A positive troponin result was associated with a clinically important increased mortality, regardless of age, even if the level was only slightly above normal. The excess mortality with a raised troponin was heavily concentrated in the first few weeks.
STUDY REGISTRATION: ClinicalTrials.gov NCT03507309.
参考来源
- Kaura A, Panoulas V, Glampson B, et al. Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres. BMJ. 2019. PMID: 31748235. doi:10.1136/bmj.l6055
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。